Join us to hear from Dr. Justin Balko from Vanderbilt University Medical Center on his research on triple negative breast cancer (TNBC) and immunotherapy. He will talk about the benefits and risks of immunotherapy and how his lab is advancing precision medicine through immunotherapy biomarkers.

Register here!